sulfinpyrazone has been researched along with Anorexia in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, C | 1 |
| Fabbian, F | 1 |
| Bordin, V | 1 |
| Di Landro, D | 1 |
1 other study available for sulfinpyrazone and Anorexia
| Article | Year |
|---|---|
Mycophenolate mofetil toxicity in an anorexic kidney transplant patient treated with sulphinpirazone.
Topics: Anorexia; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middl | 1997 |